Astrana Current Deferred Revenue from 2010 to 2024
| ASTH Stock | 33.48 0.01 0.03% |
Current Deferred Revenue | First Reported 2009-06-30 | Previous Quarter 2.6 M | Current Value 2.2 M | Quarterly Volatility 8.2 M |
Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 16.9 M, Other Operating Expenses of 1.4 B or Operating Income of 88.8 M, as well as many indicators such as Price To Sales Ratio of 1.33, Dividend Yield of 0.0428 or PTB Ratio of 4.22. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.
Astrana | Current Deferred Revenue |
Latest Astrana Health's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Astrana Health over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Astrana Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Astrana Health's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Astrana Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 3,718,697 | |
| Geometric Mean | 856,441 | |
| Coefficient Of Variation | 148.11 | |
| Mean Deviation | 4,456,410 | |
| Median | 622,706 | |
| Standard Deviation | 5,507,627 | |
| Sample Variance | 30.3T | |
| Range | 16.7M | |
| R-Value | 0.39 | |
| Mean Square Error | 27.7T | |
| R-Squared | 0.15 | |
| Significance | 0.15 | |
| Slope | 478,691 | |
| Total Sum of Squares | 424.7T |
Astrana Current Deferred Revenue History
About Astrana Health Financial Statements
Investors use fundamental indicators, such as Astrana Health's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 744 K | 706.8 K |
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out the analysis of Astrana Health Correlation against competitors. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.